$48.03 $1.60 per serving
Product analysis
Boost combines ingredients linked to memory and attention, with support that is limited and depends on the preparation. Undisclosed blend contents make comparison with studied preparations harder.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
Choline has a reasonable identified form, but most other preparation qualities remain uncertain. Missing forms and mixture breakdowns prevent a clear picture of the complete formula.
Ingredient Transparency68
Amounts and several forms are stated. The alpha-lipoic-acid mixture and botanical blend lack breakdowns, so their individual contributions remain unclear.
Value For Money27
Several ingredients, including choline and acetyl L-carnitine, are relatively costly within the serving. Value for the remaining preparations is uncertain.
Customer Satisfaction74
Customers are generally satisfied with their purchases. Several hundred ratings offer a useful view of satisfaction, without showing whether the supplement works.
Product Focus34
The formula targets memory and attention, but the clearest findings are limited, mixed or specific to other preparations and populations. Several small ingredient amounts and an undisclosed blend further limit confidence in a useful everyday cognitive effect.
- Format
Capsule - Container
- 90 Capsule(s)
- Per serving
- $1.60
- Customer rating
- 4.7 · 349 ratings
Goals
Impact
High effect
Huperzine · 100 mcgBacopa · 50 mg
Huperzine connects to acetylcholine signalling, but its mechanism does not establish routine healthy-adult cognitive benefit. Bacopa’s memory findings depend on identified studied extracts, which are not specified here. Phosphatidylserine and ginkgo have limited or inconsistent general-adult findings, so their presence does not establish better everyday memory.
How this product is rated for Brain Health
Ingredient fit66
The formula includes relevant ingredients alongside other actives, so its overall focus extends beyond brain health. The declared amounts provide partial support in the saved comparison, with some below its reference amounts.
Goal fit
The formula includes relevant ingredients alongside other actives, so its overall focus extends beyond brain health.
Dose adequacy
The declared amounts provide partial support in the saved comparison, with some below its reference amounts.
Pathways54
The mapped emphasis is acetylcholine signalling. Coverage elsewhere is limited.
Depth
The strongest mapped contribution concerns acetylcholine signalling; this describes the ingredient connection, not a demonstrated cognitive outcome.
Breadth
Substantial coverage is concentrated in one mapped area rather than spread across several aspects of brain function.
Evidence86
The saved findings give Huperzine the leading evidence position. Its biological role and the supplied population and preparation limits determine the practical claim.
Evidence strength
Huperzine leads the saved evidence comparison, but the supplied scientific limitations still constrain what cognitive benefits can be expected.
Studied preparation
Preparation support is incomplete; Phosphatidylserine lacks a studied match in the saved findings.
Formulation logic100
No unmet partner requirement or configured conflict was identified. Amount thresholds describe the saved comparison and do not establish extra benefit from the combination.
Partner coverage
The relevant ingredients have no unmet partner requirement in the supplied findings; this does not establish an added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The counted ingredients pass the saved minimum amount threshold; that threshold is not proof of cognitive effectiveness.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Moderate effect
Choline · 10 mgAcetyl L-Carnitine · 75 mgHuperzine · 100 mcg
Bacopa and ginkgo provide the clearest cognitive connection, but the supplied evidence is small, mixed and preparation dependent. Bacopa is only 50 mg here, and the saved assessment does not fully match its preparation to the reviewed extract. Choline, acetyl L-carnitine and phosphatidylserine have cognitive roles without clear evidence for an immediate standalone attention benefit.
How this product is rated for Mental Focus
Ingredient fit56
The blend serves broader purposes, with only part of its assessed ingredients directed at focus. The counted amounts broadly support the supplied comparison ranges, although support varies by ingredient.
Goal fit
The blend serves broader purposes, with only part of its assessed ingredients directed at focus.
Dose adequacy
The counted amounts broadly support the supplied comparison ranges, although support varies by ingredient.
Pathways12
The strongest assessed connection is cerebral energy supply, with limited coverage. No mechanism reaches the saved broader-coverage threshold.
Depth
The strongest assessed connection is cerebral energy supply, with limited coverage.
Breadth
No mechanism reaches the saved broader-coverage threshold.
Evidence53
Ginkgo provides the strongest relevant evidence among ingredients counted at meaningful amounts. The findings remain specific to the reviewed context. Only part of the assessed contribution matches preparations accepted in the reviewed evidence.
Evidence strength
Ginkgo provides the strongest relevant evidence among ingredients counted at meaningful amounts. The findings remain specific to the reviewed context.
Studied preparation
Only part of the assessed contribution matches preparations accepted in the reviewed evidence.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No ingredient conflict was identified in the saved assessment. 2 of 2 counted ingredients reach the saved meaningful-amount threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No ingredient conflict was identified in the saved assessment.
Effective doses
2 of 2 counted ingredients reach the saved meaningful-amount threshold.
Huperzine Not classified
No linked studies yet.
Impact
Moderate effect
Acetyl L-Carnitine · 75 mgAcetyl L-Carnitine · 75 mgHuperzine · 100 mcg
Bacopa is associated with memory and information-processing outcomes after repeated use, but benefits depend on the specific preparation; a 50 mg declaration alone does not establish that match. Ginkgo findings are mixed, while phosphatidylserine, huperzine and acetyl L-carnitine have limited evidence that applies to routine productivity in healthy adults.
How this product is rated for Productivity Boost
Ingredient fit54
The saved assessment identifies goal-related ingredients, although their practical relevance depends on the evidence and preparation. The saved amount assessment is partial across the ingredients it counts.
Goal fit
The saved assessment identifies goal-related ingredients, although their practical relevance depends on the evidence and preparation.
Dose adequacy
The saved amount assessment is partial across the ingredients it counts.
Pathways7
The strongest saved contribution is to the brain-function pathway, with limited overall coverage. None of the listed pathways reaches the saved coverage threshold.
Depth
The strongest saved contribution is to the brain-function pathway, with limited overall coverage.
Breadth
None of the listed pathways reaches the saved coverage threshold.
Evidence47
Ginkgo provides the strongest evidence contribution among the ingredients counted at qualifying amounts. Some preparation matches remain incomplete.
Evidence strength
Ginkgo provides the strongest evidence contribution among the ingredients counted at qualifying amounts.
Studied preparation
Preparation matching is incomplete for Huperzine; the remaining qualifying ingredients have a saved preparation match.
Formulation logic100
The saved assessment finds the required ingredient relationships satisfied and no configured conflicts; all counted ingredients meet its minimum amount criterion.
Partner coverage
The counted ingredients can contribute alone or have their required partner present.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
2 of 2 counted ingredients meet the saved minimum amount criterion; that criterion is not a promise of benefit.
Impact
High effect
Choline · 10 mgAstaxanthin · 300 mcgHuperzine · 100 mcgAcetyl L-Carnitine · 75 mgBacopa · 50 mg
Huperzine affects acetylcholine breakdown, but its cited evidence comes from Alzheimer's disease rather than routine healthy-adult cognitive use. Ginkgo has preliminary preparation-specific attention findings, while phosphatidylserine findings are inconsistent; the declared materials do not establish equivalence to studied preparations. These three receive the saved contributions. The small bacopa, acetyl L-carnitine, choline and astaxanthin amounts are not counted and do not establish additional cognitive benefits.
How this product is rated for Cognitive Support
Ingredient fit69
Huperzine, ginkgo and phosphatidylserine receive contributions; several other cognitive ingredients are excluded for their low amounts.
Goal fit
The credited cognitive ingredients share the formula with other actives, reducing its saved focus.
Dose adequacy
Huperzine reaches its full saved amount anchor; ginkgo and phosphatidylserine receive partial coverage.
Pathways60
The saved contribution is dominated by huperzine in acetylcholine signalling, with smaller blood-flow and nerve-structure contributions.
Depth
Acetylcholine signalling reaches full saved coverage through huperzine.
Breadth
Only acetylcholine signalling meets the saved coverage threshold.
Evidence79
Huperzine leads the saved evidence contribution; ginkgo and phosphatidylserine lack verified studied-preparation identity.
Evidence strength
Huperzine supplies the strongest saved evidence finding, with disease-cohort limits on its relevance.
Studied preparation
Huperzine receives preparation recognition; the counted ginkgo and phosphatidylserine do not.
Formulation logic100
The counted ingredients need no missing partners, and no configured conflict was found.
Partner coverage
All counted ingredients satisfy the saved partner requirements.
Conflicts
None of the configured ingredient conflicts was matched.
Effective doses
The three counted ingredients pass the saved minimum amount threshold; the other four assessed ingredients fall below it.
Phospholipids (unspecified) Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Olive leaf extract (Oleuropein) | 5 mg | |
Choline (Choline Bitartrate) | 10 mg | |
N-Acetyl-L-Cysteine | 200 mg | |
Lipoic Acid (Alpha Lipoic, R-Lipoic Acid) | 120 mg | |
Phosphatidylserine (Phosphatidylserine Complex) | 100 mg | |
Acetyl-L-Carnitine (Acetyl-L-Carnitine HCl) | 75 mg | |
Ginkgo biloba extract | 60 mg | |
Bacopa | 50 mg | |
Pyrroloquinoline Quinone | 5 mg | |
Astaxanthin (Haematoccous pluvialis) | 300 mcg | |
Huperzine A (Huperzia serrata) | 100 mcg | |
Brain Support Blue Whole Food Blend | 50 mg |
Huperzine (Huperzia serrata) · 100 mcg OverallScore47
A serving supplies 100 mcg of Huperzine A, an amount the evaluation considers targeted. Specific cycling guidance is not established in the available information.
How this ingredient is rated
Active Ingredient Quality & Bioavailability20
The label identifies huperzine and a Huperzia serrata source, but an extract or standardization percentage is not established.
Source and Standardization Clarity
The label identifies huperzine and a Huperzia serrata source, but an extract or standardization percentage is not established.
Dose, Safety & Label Transparency88
The 100 mcg amount per serving is stated, while specific cycling guidance is not established in the available information.
Huperzine A Dosage Efficacy
The serving provides 100 mcg of Huperzine A, an amount the evaluation considers targeted.
Cycling Guidance and Transparency
The 100 mcg amount is recorded, but specific cycling guidance is not established in the available information.
Value20
Based on the whole-product price, about $1.60 per 100 mcg of Huperzine A is relatively high in the evaluation’s comparison.
Price per 100mcg of Huperzine A
The whole-product price works out to about $1.60 per 100 mcg of Huperzine A, relatively high in the evaluation’s comparison.
Acetyl L-Carnitine (Acetyl-L-Carnitine HCl) · 75 mg OverallScore53
Each serving provides 75 mg of acetyl L-carnitine HCl, a relatively small amount. The whole-product price works out to about $10.67 per 500 mg of acetyl L-carnitine, a relatively high cost for this ingredient.
How this ingredient is rated
Active Ingredient Quality & Bioavailability88
Acetyl L-carnitine is the only carnitine form identified in the available facts. The available facts identify the HCl form and record no purity or manufacturing claim.
ALCAR vs. Standard Carnitine Form
Acetyl L-carnitine is the only carnitine form identified in the available facts.
Advanced Sourcing and Salt Specificity
The available facts identify the HCl form and record no purity or manufacturing claim.
Dose, Safety & Label Transparency44
Each serving contains 75 mg of acetyl L-carnitine, with its amount individually disclosed.
Clinical Dosage Efficacy
A serving provides 75 mg of acetyl L-carnitine, a relatively small amount.
Label Transparency and Proprietary Blends
The 75 mg amount of acetyl L-carnitine per serving is individually disclosed.
Value0
The whole-product price works out to about $10.67 per 500 mg of acetyl L-carnitine, a relatively high cost for this ingredient.
Price per 500mg Acetyl L-Carnitine
The whole-product price works out to about $10.67 per 500 mg of acetyl L-carnitine, a relatively high cost for this ingredient.
Choline (Choline Bitartrate) · 10 mg OverallScore50
Each serving provides 10 mg of choline from choline bitartrate. The whole-product price works out to about $16.01 per 100 mg of choline, which is relatively high on this basis.
How this ingredient is rated
Active Ingredient Quality & Bioavailability68
Choline bitartrate is a standard form used for general choline intake. The stored ingredient information also indicates a standard processing aid.
Choline Form Efficacy & Bioavailability
Choline bitartrate is a standard form used for general choline intake.
Formula Purity & Excipient Quality
The stored ingredient information indicates a standard processing aid and no flagged additives.
Dose, Safety & Label Transparency47
Each serving lists 10 mg of choline and identifies choline bitartrate as its source.
Choline Dose by Declared Basis
Each serving provides 10 mg of choline.
Elemental Yield Transparency
The label specifies the choline amount and names choline bitartrate as its source.
Value20
At about $16.01 per 100 mg of choline based on the whole-product price, the cost is relatively high on this basis.
Price per 100 mg of Declared Choline Basis
At about $16.01 per 100 mg of choline based on the whole-product price, the cost is relatively high on this basis.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
- Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
- Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
- Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
- Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.